Short telomeres in mitochondrial DNA depletion disorders.

Patients with mitochondrial DNA depletion disorders (MDDs) had shorter telomere lengths overall compared to healthy controls.

• Telomere length was measured in lymphocytes, granulocytes, T cells, and B cells.
• Comparisons were made between a cohort of MDD patients and healthy controls.
• MDDs are rare, genetically diverse conditions marked by significant reduction in mtDNA, primarily affecting energy-demanding tissues such as muscle, liver, and brain.

The most significant differences in telomere length between MDD patients and healthy controls were observed in granulocytes.

• Telomere length was assessed across multiple cell types: lymphocytes, granulocytes, T cells, and B cells.
• Granulocytes showed the most pronounced telomere length differences compared to other cell types measured.
• The study design allowed for cell-type-specific comparison of telomere length between patients and controls.

The association between mtDNA depletion and shorter telomeres may provide insight into MDD pathophysiology.

• The authors suggest the finding of shorter telomeres in MDD patients may be mechanistically informative regarding disease pathophysiology.
• MDDs sometimes lead to catastrophic multisystem failure, affecting energy-demanding tissues such as muscle, liver, and brain.
• The observation links mitochondrial dysfunction with telomere biology.

Telomere length has potential as a biomarker in mitochondrial disease, though further study is needed.

• The authors propose telomere length measurement in lymphocytes, granulocytes, T cells, and B cells as a candidate biomarker approach.
• The authors note that further study is needed before telomere length can be established as a biomarker in mitochondrial disease.
• MDDs are described as genetically diverse, which may affect the generalizability of telomere length as a uniform biomarker.